IRIS Accounts Production v24.1.9.2 07974307 Board of Directors Board of Directors 1.4.23 31.3.24 31.3.24 false true false false false true false iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pureutr:tonnesutr:kWh079743072023-03-31079743072024-03-31079743072023-04-012024-03-31079743072022-03-31079743072022-04-012023-03-31079743072023-03-3107974307ns15:EnglandWales2023-04-012024-03-3107974307ns14:PoundSterling2023-04-012024-03-3107974307ns10:Director12023-04-012024-03-3107974307ns10:Director22023-04-012024-03-3107974307ns10:PrivateLimitedCompanyLtd2023-04-012024-03-3107974307ns10:SmallEntities2023-04-012024-03-3107974307ns10:AuditExempt-NoAccountantsReport2023-04-012024-03-3107974307ns10:SmallCompaniesRegimeForDirectorsReport2023-04-012024-03-3107974307ns10:SmallCompaniesRegimeForAccounts2023-04-012024-03-3107974307ns10:FullAccounts2023-04-012024-03-310797430712023-04-012024-03-3107974307ns10:RegisteredOffice2023-04-012024-03-3107974307ns5:CurrentFinancialInstruments2024-03-3107974307ns5:CurrentFinancialInstruments2023-03-3107974307ns5:ShareCapital2024-03-3107974307ns5:ShareCapital2023-03-3107974307ns5:RetainedEarningsAccumulatedLosses2024-03-3107974307ns5:RetainedEarningsAccumulatedLosses2023-03-3107974307ns5:NetGoodwill2023-04-012024-03-3107974307ns5:IntangibleAssetsOtherThanGoodwill2023-04-012024-03-3107974307ns5:PlantMachinery2023-04-012024-03-3107974307ns5:FurnitureFittings2023-04-012024-03-3107974307ns5:ComputerEquipment2023-04-012024-03-3107974307ns5:NetGoodwill2023-03-3107974307ns5:NetGoodwill2024-03-3107974307ns5:NetGoodwill2023-03-3107974307ns5:PlantMachinery2023-03-3107974307ns5:FurnitureFittings2023-03-3107974307ns5:ComputerEquipment2023-03-3107974307ns5:PlantMachinery2024-03-3107974307ns5:FurnitureFittings2024-03-3107974307ns5:ComputerEquipment2024-03-3107974307ns5:PlantMachinery2023-03-3107974307ns5:FurnitureFittings2023-03-3107974307ns5:ComputerEquipment2023-03-3107974307ns5:CurrentFinancialInstrumentsns5:WithinOneYear2024-03-3107974307ns5:CurrentFinancialInstrumentsns5:WithinOneYear2023-03-31
REGISTERED NUMBER: 07974307 (England and Wales)














Financial Statements for the Year Ended 31 March 2024

for

Npsych Clinical Neurosciences Ltd

Npsych Clinical Neurosciences Ltd (Registered number: 07974307)






Contents of the Financial Statements
for the Year Ended 31 March 2024




Page

Company Information 1

Statement of Financial Position 2

Notes to the Financial Statements 4


Npsych Clinical Neurosciences Ltd

Company Information
for the Year Ended 31 March 2024







DIRECTORS: Dr N H Walton
Dr R J McCarter





REGISTERED OFFICE: The Retreat
406 Roding Lane South
Woodford Green
Essex
IG8 8EY





REGISTERED NUMBER: 07974307 (England and Wales)





ACCOUNTANTS: Nordens
The Retreat
406 Roding Lane South
Woodford Green
Essex
IG8 8EY

Npsych Clinical Neurosciences Ltd (Registered number: 07974307)

Statement of Financial Position
31 March 2024

31.3.24 31.3.23
Notes £    £    £    £   
FIXED ASSETS
Intangible assets 4 - -
Property, plant and equipment 5 13,949 15,764
13,949 15,764

CURRENT ASSETS
Debtors 6 115,462 198,241
Cash at bank and in hand 481,263 336,167
596,725 534,408
CREDITORS
Amounts falling due within one year 7 108,762 75,900
NET CURRENT ASSETS 487,963 458,508
TOTAL ASSETS LESS CURRENT LIABILITIES 501,912 474,272

CAPITAL AND RESERVES
Called up share capital 100 100
Retained earnings 501,812 474,172
SHAREHOLDERS' FUNDS 501,912 474,272

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 31 March 2024.

The members have not required the company to obtain an audit of its financial statements for the year ended 31 March 2024 in accordance with Section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for:
(a)ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and
(b)preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

Npsych Clinical Neurosciences Ltd (Registered number: 07974307)

Statement of Financial Position - continued
31 March 2024


The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Income Statement has not been delivered.

The financial statements were approved by the Board of Directors and authorised for issue on 7 August 2024 and were signed on its behalf by:




Dr N H Walton - Director



Dr R J McCarter - Director


Npsych Clinical Neurosciences Ltd (Registered number: 07974307)

Notes to the Financial Statements
for the Year Ended 31 March 2024

1. STATUTORY INFORMATION

Npsych Clinical Neurosciences Ltd is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.

2. ACCOUNTING POLICIES

Basis of preparing the financial statements
These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

Turnover
Revenue is measured at the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes.

Goodwill
Goodwill, being the amount paid in connection with the acquisition of a business in 2012, is being amortised evenly over its estimated useful life of ten years.

The directors have reviewed the value of goodwill and its remaining life and believe that the amounts shown in the financial statements for goodwill and goodwill amortisation are fairly stated.

Intangible assets
Intangible assets are initially measured at cost. After initial recognition, intangible assets are measured at cost less any accumulated amortisation and any accumulated impairment losses.

Tangible fixed assets
Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful life.
Plant and machinery - 15% on reducing balance
Fixtures and fittings - 15% on reducing balance
Computer equipment - 25% on reducing balance

Pension costs and other post-retirement benefits
The company operates a defined contribution pension scheme. Contributions payable to the company's pension scheme are charged to profit or loss in the period to which they relate.

3. EMPLOYEES AND DIRECTORS

The average number of employees during the year was 2 (2023 - 2 ) .

Npsych Clinical Neurosciences Ltd (Registered number: 07974307)

Notes to the Financial Statements - continued
for the Year Ended 31 March 2024

4. INTANGIBLE FIXED ASSETS
Goodwill
£   
COST
At 1 April 2023
and 31 March 2024 800,000
AMORTISATION
At 1 April 2023
and 31 March 2024 800,000
NET BOOK VALUE
At 31 March 2024 -
At 31 March 2023 -

5. PROPERTY, PLANT AND EQUIPMENT
Fixtures
Plant and and Computer
machinery fittings equipment Totals
£    £    £    £   
COST
At 1 April 2023 16,325 10,312 41,099 67,736
Additions - - 2,431 2,431
At 31 March 2024 16,325 10,312 43,530 70,167
DEPRECIATION
At 1 April 2023 13,822 9,600 28,550 51,972
Charge for year 376 125 3,745 4,246
At 31 March 2024 14,198 9,725 32,295 56,218
NET BOOK VALUE
At 31 March 2024 2,127 587 11,235 13,949
At 31 March 2023 2,503 712 12,549 15,764

6. DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
31.3.24 31.3.23
£    £   
Trade debtors 110,755 193,174
Other debtors 4,707 5,067
115,462 198,241

Npsych Clinical Neurosciences Ltd (Registered number: 07974307)

Notes to the Financial Statements - continued
for the Year Ended 31 March 2024

7. CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
31.3.24 31.3.23
£    £   
Trade creditors 3,785 5,594
Taxation and social security 101,533 69,436
Other creditors 3,444 870
108,762 75,900

8. RELATED PARTY DISCLOSURES

The Directors Dr N H Walton and Dr R J McCarter are considered to be the key management personnel.